Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,057 | -3,587 | -2,864 | -1,542 | -5,263 |
| Accounts receivable | -556 | N/A | N/A | N/A | 96 |
| Accounts payable and accrued liabilities | -445 | -531 | -547 | -456 | -1,772 |
| Other Working Capital | -1,538 | -1,246 | -478 | -510 | -4,601 |
| Other Operating Activity | 1,263 | 671 | 912 | 637 | -9,705 |
| Operating Cash Flow | $-4,333 | $-4,693 | $-2,977 | $-1,871 | $-21,245 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 0 | 10,402 |
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $10,402 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 24 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | 5,000 |
| Financing Cash Flow | $N/A | $0 | $N/A | $N/A | $5,024 |
| Exchange Rate Effect | -6 | -6 | -6 | -4 | 8 |
| Beginning Cash Position | 7,571 | 7,571 | 7,571 | 7,571 | 13,382 |
| End Cash Position | 3,232 | 2,872 | 4,588 | 5,696 | 7,571 |
| Net Cash Flow | $-4,339 | $-4,699 | $-2,983 | $-1,875 | $-5,811 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,333 | -4,693 | -2,977 | -1,871 | -21,245 |
| Free Cash Flow | -4,333 | -4,693 | -2,977 | -1,871 | -21,245 |